HeartBeam's Portable ECG Technology Poised to Transform Cardiac Care

HeartBeam Inc. (NASDAQ: BEAT) is developing a portable, credit-card-sized device and proprietary software capable of capturing heart signals in three non-coplanar dimensions and reconstructing those signals into a full synthesized 12-lead ECG. The importance of such innovation is underscored by the widespread impact of heart disease, particularly heart rhythm problems that affect millions worldwide. The VALID-ECG study results carry significant weight for both clinical adoption and HeartBeam's commercialization pathway, providing validation for the technology's medical-grade accuracy.

For HeartBeam, the upcoming commercialization of its ECG system represents more than a regulatory milestone; it is a potential step toward redefining how heart disease is detected and treated. By combining portability with medical-grade accuracy, the company is creating a tool that could improve lives through earlier intervention, fewer hospitalizations and faster responses to arrhythmias. This technology addresses critical gaps in current cardiac care by enabling comprehensive heart monitoring outside traditional medical facilities.

The company's platform technology represents the first-ever cable-free 12-lead ECG capable of capturing the heart's electrical signals from three dimensions. This breakthrough allows physicians to identify cardiac health trends and acute conditions and direct patients to appropriate care outside of medical facilities. With study results validating its technology and commercialization plans advancing, HeartBeam stands poised not only to capture a significant market opportunity but also to play a vital role in the future of patient-centered cardiac care.

HeartBeam's intellectual property portfolio includes 13 U.S. and 4 international-issued patents related to technology enablement, providing strong protection for its innovative approach to cardiac monitoring. The company's dedication to transforming cardiac care by providing powerful cardiac insights wherever the patient is aligns with growing trends toward decentralized healthcare and remote patient monitoring. More information about the company's technology and developments can be found at https://www.HeartBeam.com and additional news updates are available at https://ibn.fm/BEAT.